In one study, colchicine treatment was associated with reduced CRP levels and the clinical severity among individuals with COVID‐19, whereas D‐dimer levels, all‐cause mortality, and rates of mechanical ventilation were unchanged. The gene discussed is CRP; the disease is COVID-19.